ADEM
Distinct disease or part of the MS spectrum?
Citation Manager Formats
Make Comment
See Comments
This article has a correction. Please see:
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the CNS affecting predominantly children and young adults. Typically, it is antedated by an infectious illness, most commonly measles, mumps, influenza A or B, Rocky Mountain spotted fever, or hepatitis A or B, or infection with herpes simplex, human herpesvirus 6, varicella, rubella, vaccinia, Epstein–Barr virus, cytomegalovirus, Mycoplasma pneumoniae, Chlamydia, Legionella, Campylobacter, or Streptococci. ADEM can also follow immunizations: rabies, diphtheria–tetanus–pertussis, smallpox, measles, Japanese B encephalitis, and hog.1,2⇓ Characteristic clinical features include sudden onset of multifocal neurologic disturbances such as bilateral optic neuritis, visual field defects, aphasia, motor and sensory deficits, ataxia, movement disorders, and signs of an acute meningoencephalopathy with meningismus, a depressed level of consciousness, focal or generalized seizures, and psychosis. Maximal deficits are reached within several days and remission may be similarly rapid. More often, however, resolution is partial and takes weeks or months. High mortality rates (up to 20%) were frequent in the past, particularly when ADEM followed measles. However, with the introduction of effective vaccination strategies and the decline of measles, death is rare.2 MRI reveals multifocal areas of increased signal intensity on T2-weighted sequences that commonly enhance synchronously with contrast medium.3,4⇓ Extensive perifocal edema may be seen. White matter involvement predominates but gray matter can also be affected, particularly basal ganglia, thalami, and brainstem. Lesions may also be restricted to the brainstem or cerebellum. Tumor-like lesions also occur. CSF usually shows pleocytosis but only rarely intrathecal oligoclonal immunoglobulin (Ig) G production, which almost invariably ceases as patients improve. Whereas high-dose steroids, plasma exchange, IVIg, immunomodulators, and hypothermia have been tried, no treatment is established.5-9⇓⇓⇓⇓ This textbook view of ADEM is based on a compilation of features extracted from single cases and small …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Deborah Friedman and Dr. Stacy Smith
► Watch
Related Articles
Alert Me
Recommended articles
-
Article
Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritisSudarshini Ramanathan, Stephen W. Reddel, Andrew Henderson et al.Neurology - Neuroimmunology Neuroinflammation, October 29, 2014 -
Views & Reviews
International consensus diagnostic criteria for neuromyelitis optica spectrum disordersDean M. Wingerchuk, Brenda Banwell, Jeffrey L. Bennett et al.Neurology, June 19, 2015 -
Article
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disordersDouglas Kazutoshi Sato, Dagoberto Callegaro, Marco Aurelio Lana-Peixoto et al.Neurology, January 10, 2014 -
Articles
The clinical features, MRI findings, and outcome of optic neuritis in childrenM. Wilejto, M. Shroff, J. R. Buncic et al.Neurology, July 24, 2006